Stougaard EB, Rossing P, Cherney D, Vistisen D, et al. Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines. J Diabetes Complications 2022 Jul 9:108257. doi: 10.1016/j.jdiacomp.2022.108257.
PMID: 35840519